Búsqueda | BVS Medicinas Tradicionales, Complementarias, e Integrativas en las Américas

1.

Adjuvant chemotherapy in operable breast cancer: cyclophosphamide, methotrexate, and fluorouracil versus chlorambucil, methotrexate, and fluorouracil--11-year results of Swiss Group for Clinical Cancer Research trial SAKK 27/82.

Senn, H J; Maibach, R; Castiglione, M; Jungi, W F; Cavalli, F; Leyvraz, S; Obrecht, J P; Schildknecht, O; Siegenthaler, P.

J Clin Oncol ; 15(7): 2502-9, 1997 Jul.

Artículo en Inglés | MEDLINE | ID: mdl-9215818

2.

Burdens and benefits of adjuvant cyclophosphamide, methotrexate, and fluorouracil and tamoxifen for elderly patients with breast cancer: the International Breast Cancer Study Group Trial VII.

Crivellari, D; Bonetti, M; Castiglione-Gertsch, M; Gelber, R D; Rudenstam, C M; Thürlimann, B; Price, K N; Coates, A S; Hürny, C; Bernhard, J; Lindtner, J; Collins, J; Senn, H J; Cavalli, F; Forbes, J; Gudgeon, A; Simoncini, E; Cortes-Funes, H; Veronesi, A; Fey, M; Goldhirsch, A.

J Clin Oncol ; 18(7): 1412-22, 2000 Apr.

Artículo en Inglés | MEDLINE | ID: mdl-10735888

3.

Swiss adjuvant trials in women with node-negative breast cancer. OSAKO.

Jungi, W F; Senn, H J.

J Natl Cancer Inst Monogr ; (11): 71-6, 1992.

Artículo en Inglés | MEDLINE | ID: mdl-1627433

4.

Retreating recurrent breast cancer with the same CMF-containing regimen used as adjuvant therapy. The International Breast Cancer Study Group.

Castiglione-Gertsch, M; Tattersall, M; Hacking, A; Goldhirsch, A; Gudgeon, A; Gelber, R D; Lindtner, J; Coates, A; Collins, J; Isley, M; Senn, H J; Rudenstam, C M.

Eur J Cancer ; 33(14): 2321-5, 1997 Dec.

Artículo en Inglés | MEDLINE | ID: mdl-9616275

5.

Prognostic impact of amenorrhoea after adjuvant chemotherapy in premenopausal breast cancer patients with axillary node involvement: results of the International Breast Cancer Study Group (IBCSG) Trial VI.

Pagani, O; O'Neill, A; Castiglione, M; Gelber, R D; Goldhirsch, A; Rudenstam, C M; Lindtner, J; Collins, J; Crivellari, D; Coates, A; Cavalli, F; Thürlimann, B; Simoncini, E; Fey, M; Price, K; Senn, H J.

Eur J Cancer ; 34(5): 632-40, 1998 Apr.

Artículo en Inglés | MEDLINE | ID: mdl-9713266

6.

Adjuvant chemoimmunotherapy with LMF plus BCG in node-negative and node-positive breast cancer - intermediate report at 4 years.

Senn, H J; Amgwerd, R; Jungi, W F; Hochuli, R; Ammann, J; Engelhart, G; Heinz, C; Wick, A; Enderlin, F; Creux, G; Simon, B; Lanz, R; Bigler, R; Seiler, S.

Recent Results Cancer Res ; 80: 177-84, 1982.

Artículo en Inglés | MEDLINE | ID: mdl-7036281

7.

[Truth at the bedside--also with cancer patients?]. / Wahrhaftigkeit am Krankenbett--auch bei Tumorpatienten?

Senn, H J; Glaus, A.

Schweiz Rundsch Med Prax ; 80(9): 200-5, 1991 Feb 26.

Artículo en Alemán | MEDLINE | ID: mdl-2014376

8.

Adjuvant chemotherapy in breast cancer--Swiss co-operative studies.

Senn, H J; Mayr, A C.

Cancer Treat Rev ; 6 Suppl: 79-85, 1979 Jun.

Artículo en Inglés | MEDLINE | ID: mdl-387231

9.

Adjuvant chemoimmunotherapy with LMF + BCG in node-negative and node-positive breast cancer: 8 year results.

Senn, H J; Jungi, W F; Amgwerd, R; Hochuli, E; Ammann, J; Engelhart, G; Heinz, C; Wick, A; Enderlin, F; Creux, G.

Recent Results Cancer Res ; 96: 90-101, 1984.

Artículo en Inglés | MEDLINE | ID: mdl-6528092

10.

[Alternative treatment methods in cancer]. / Alternative Behandlungsmethoden bei Krebskrankheiten.

Jungi, W F; Senn, H J.

Med Monatsschr Pharm ; 19(1): 6-16, 1996 Jan.

Artículo en Alemán | MEDLINE | ID: mdl-8583981

11.

Paracelsus, scientific research and supportive care--500 years after!

Senn, H J.

Support Care Cancer ; 1(5): 230-2, 1993 Sep.

Artículo en Inglés | MEDLINE | ID: mdl-7512410

12.

Adjuvant chemoimmunotherapy with LMF + BCG in node-negative and node-positive breast cancer patients: 10 year results.

Senn, H J; Barett-Mahler, A R; Jungi, W F.

Eur J Cancer Clin Oncol ; 25(3): 513-25, 1989 Mar.

Artículo en Inglés | MEDLINE | ID: mdl-2703006

13.

[Why do cancer patients use alternative medicine?]. / Warum benützen Tumorpatienten Alternativmedizin?

Morant, R; Jungi, W F; Koehli, C; Senn, H J.

Schweiz Med Wochenschr ; 121(27-28): 1029-34, 1991 Jul 09.

Artículo en Alemán | MEDLINE | ID: mdl-1882214

14.

Swiss adjuvant trial (OSAKO 06/74) with chlorambucil, methotrexate, and 5-fluorouracil plus BCG in node-negative breast cancer patients: nine-year results.

Senn, H J; Jungi, W F; Amgwerd, R; Hochuli, E; Ammann, J; Engelhart, G; Heinz, C; Wick, A; Enderlin, F; Creux, G.

NCI Monogr ; (1): 129-34, 1986.

Artículo en Inglés | MEDLINE | ID: mdl-3534585

15.

Interaction of tamoxifen with concurrent cytotoxic adjuvant treatment affects lymphocytes and lymphocyte subsets counts in breast cancer patients.

Sabbioni, M E; Castiglione, M; Hürny, C; Siegrist, H P; Bacchi, M; Bernhard, J; Thürlimann, B; Bonnefoi, H; Perey, L; Goldhirsch, A; Senn, H J.

Support Care Cancer ; 7(3): 149-53, 1999 May.

Artículo en Inglés | MEDLINE | ID: mdl-10335933

16.

The effect of adjuvant prednisone combined with CMF on patterns of relapse and occurrence of second malignancies in patients with breast cancer. International (Ludwig) Breast Cancer Study Group.

Marini, G; Murray, S; Goldhirsch, A; Gelber, R D; Castiglione-Gertsch, M; Price, K N; Tattersall, M H; Rudenstam, C M; Collins, J; Lindtner, J; Cavalli, F; Cortés-Funes, H; Gudgeon, A; Forbes, J F; Galligioni, E; Coates, A S; Senn, H J.

Ann Oncol ; 7(3): 245-50, 1996 Mar.

Artículo en Inglés | MEDLINE | ID: mdl-8740787

17.

[Breast neoplasms. Progress by means of adjuvant chemotherapy?]. / Mammakarzinom Fortschritt durch adjuvante Chemotherapie?

Senn, H J.

MMW Munch Med Wochenschr ; 122(1): 10-5, 1980 Jan 04.

Artículo en Alemán | MEDLINE | ID: mdl-6767909

18.

[Adjuvant chemotherapy in breast cancer]. / Adjuvante Chemotherapie beim Mammakarzinom.

Senn, H J.

Dtsch Med Wochenschr ; 106(48): 1626-30, 1981 Nov 27.

Artículo en Alemán | MEDLINE | ID: mdl-7030686

19.

Divergent effect of adjuvant chemo-immunotherapy on recurrence rates in node-negative and node-positive breast cancer patients.

Jungi, W F; Senn, H J; Amgwerd, R; Hochuli, E.

Eur J Cancer (1965) ; Suppl 1: 169-72, 1980.

Artículo en Inglés | MEDLINE | ID: mdl-7032928

20.

Adjuvant chemo-immuno-therapy with LMF+BCG in node-negeative and node-positive breast cancer.

Senn, H J; Jungi, W F; Amgwerd, R; Sprenger, F; Hochuli, E; Engelhart, G; Heinz, C; Wick, A; Enderlin, F; Simeon, B; Lanz, R; Bigler, R.

Haematol Blood Transfus ; 22: 47-60, 1978.

Artículo en Inglés | MEDLINE | ID: mdl-374199

BVS Medicinas Tradicionales, Complementarias, e Integrativas en las Américas - MTCI

Configurar filtros

Su selección (0)

Formato de exportación:

Exportar:

Adjuvant chemotherapy in operable breast cancer: cyclophosphamide, methotrexate, and fluorouracil versus chlorambucil, methotrexate, and fluorouracil--11-year results of Swiss Group for Clinical Cancer Research trial SAKK 27/82.

Burdens and benefits of adjuvant cyclophosphamide, methotrexate, and fluorouracil and tamoxifen for elderly patients with breast cancer: the International Breast Cancer Study Group Trial VII.

Swiss adjuvant trials in women with node-negative breast cancer. OSAKO.

Retreating recurrent breast cancer with the same CMF-containing regimen used as adjuvant therapy. The International Breast Cancer Study Group.

Prognostic impact of amenorrhoea after adjuvant chemotherapy in premenopausal breast cancer patients with axillary node involvement: results of the International Breast Cancer Study Group (IBCSG) Trial VI.

Adjuvant chemoimmunotherapy with LMF plus BCG in node-negative and node-positive breast cancer - intermediate report at 4 years.

[Truth at the bedside--also with cancer patients?]. / Wahrhaftigkeit am Krankenbett--auch bei Tumorpatienten?

Adjuvant chemotherapy in breast cancer--Swiss co-operative studies.

Adjuvant chemoimmunotherapy with LMF + BCG in node-negative and node-positive breast cancer: 8 year results.

[Alternative treatment methods in cancer]. / Alternative Behandlungsmethoden bei Krebskrankheiten.

Paracelsus, scientific research and supportive care--500 years after!

Adjuvant chemoimmunotherapy with LMF + BCG in node-negative and node-positive breast cancer patients: 10 year results.

[Why do cancer patients use alternative medicine?]. / Warum benützen Tumorpatienten Alternativmedizin?

Swiss adjuvant trial (OSAKO 06/74) with chlorambucil, methotrexate, and 5-fluorouracil plus BCG in node-negative breast cancer patients: nine-year results.

Interaction of tamoxifen with concurrent cytotoxic adjuvant treatment affects lymphocytes and lymphocyte subsets counts in breast cancer patients.

The effect of adjuvant prednisone combined with CMF on patterns of relapse and occurrence of second malignancies in patients with breast cancer. International (Ludwig) Breast Cancer Study Group.

[Breast neoplasms. Progress by means of adjuvant chemotherapy?]. / Mammakarzinom Fortschritt durch adjuvante Chemotherapie?

[Adjuvant chemotherapy in breast cancer]. / Adjuvante Chemotherapie beim Mammakarzinom.

Divergent effect of adjuvant chemo-immunotherapy on recurrence rates in node-negative and node-positive breast cancer patients.

Adjuvant chemo-immuno-therapy with LMF+BCG in node-negeative and node-positive breast cancer.